Abstract:Protein phosphorylation is the most significant post-translational modification for regulating cellular activities, but site-specific modulation of phosphorylation is still challenging. Using three-dimensional NMR spectra, molecular dynamics simulations, and alanine mutations, we identified that the interaction network between pT69/pS70 and R106/R109 residues prevents the phosphorylation sites from exposure to phosphatase and subsequent dephosphorylation. A Bcl-2-dephosphorylation probe, S1-6e, was designed by installing a carboxylic acid group to a Bcl-2 inhibitor. The carboxyl group competitively disrupts the interaction network between R106/R109 and pT69/pS70 and subsequently facilitates Bcl-2 dephosphorylation in living cells. As a result, S1-6e manifests a more effective apoptosis induction in pBcl-2-dependent cancer cells than other inhibitors exhibiting a similar binding affinity for Bcl-2. We believe that targeting the allosteric pathways interconnecting the core-functional domain and the phosphorylation site can be a general strategy for a rational design of site-specific dephosphorylating probes, since the allosteric pathway has been discovered in a variety of proteins.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01290?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01290</a>.List of (φ, ψ) backbone angle pairs for residues R106-D111, diagram of the phosphorylation sites of Bcl-2, 3D NMR titration spectra of different Bcl-2 variants, crystal structure of Bcl-2 isoform 2 in complex with ABT-263 or ABT-199 analogue, plot of the RMSD values of the backbone atoms in MD, binding affinity curves of BH3 peptides or compounds with different Bcl-2 variants, binding affinity curves of compounds with Bcl-xl and Mcl-1, and LC–MS spectra of the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_001.pdf">PDF</a>)MD-simulated structure of pBcl-2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_002.pdb">PDB</a>)Docking-stimulated structure of S1-6e/Bcl-2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_003.pdb">PDB</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_004.csv">CSV</a>)This article has not yet been cited by other publications.

Selective Covalent Targeting of Anti‐apoptotic BFL‐1 by a Sulfonium‐Tethered Peptide

Design, Synthesis, And Interaction Study Of Quinazoline-2(1h)-Thione Derivatives As Novel Potential Bcl-X(L) Inhibitors

Discovery and optimization of (2-naphthylthio)acetic acid derivative as selective Bfl-1 inhibitor

Discovery of a Selective and Covalent Small-Molecule Inhibitor of BFL-1 Protein That Induces Robust Apoptosis in Cancer Cells.

Development of 3‐phenyl‐n‐(2‐(3‐phenylureido)ethyl)‐thiophene‐2‐sulfonamide Compounds As Inhibitors of Antiapoptotic Bcl‐2 Family Proteins

Discovery and identification of a novel small molecule BCL-2 inhibitor that binds to the BH4 domain

Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-XL: Role of Non-Hot Spot Residues

A Conserved Hydrophobic Core At Bcl-X(L) Mediates Its Structural Stability And Binding Affinity With Bh3-Domain Peptide Of Pro-Apoptotic Protein

Cell Permeable Bcl-2 Binding Peptides: A Chemical Approach to Apoptosis Induction in Tumor Cells

Covalent inhibition of pro-apoptotic BAX

Structure Assembly of Bcl-xL Through Α5–α5 and Α6–α6 Interhelix Interactions in Lipid Membranes

Structure-Based Discovery of an Organic Compound That Binds Bcl-2 Protein and Induces Apoptosis of Tumor Cells

Targeting the Allosteric Pathway That Interconnects the Core-Functional Scaffold and the Distal Phosphorylation Sites for Specific Dephosphorylation of Bcl-2

Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors

Structure-Based Optimization of 3-Phenyl-<i>N</i>-(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors

Cyclic peptides discriminate BCL-2 and its clinical mutants from BCL-XL by engaging a single-residue discrepancy

Structure-Based Design Of Flavonoid Compounds As A New Class Of Small-Molecule Inhibitors Of The Anti-Apoptotic Bcl-2 Proteins

Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.

Discovery and development of thiazolidine-2,4-dione derivatives as Bcl-2/Mcl-1 dual inhibitors

Structure-Based Optimization of 3-Phenyl- N -(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors

De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.